Good news about the treatment of Alzheimer’s disease is hard to find. However, new breakthrough research is hailed as the “best news” in dementia research for 25 years and a potential “game changer” for people with the disease. In a preliminary trial a bioengineered medication called aducanumab has demonstrated the ability to clear accumulations of beta-amyloid proteins—a hallmark of Alzheimer’s—from the brain. Compared with subjects receiving a placebo medication, those who got monthly infusions of aducanumab in high doses appeared to experience less progressive loss in mental function.
Experimental drug slows memory loss and halts Alzheimer’s decline
More of Today's Solutions
Thailand bans plastic waste imports to combat toxic pollution
BY THE OPTIMIST DAILY EDITORIAL TEAM Thailand officially banned the import of plastic waste, a move hailed as a victory by environmental campaigners. The ...
Read More7 overlooked money tips for a stronger financial future
BY THE OPTIMIST DAILY EDITORIAL TEAM We’ve all heard the standard financial advice: stick to a budget, save for a rainy day, and avoid ...
Read MoreNew nasal spray treatment could help prevent Alzheimer’s
According to the World Health Organization, around 55 million people worldwide suffer from dementia. Although there’s currently no cure, researchers are unabatedly looking for ...
Read MoreFeeling the gym blues? 7 strategies to kick your body comparison habit
You've prepared for that sizzling aerobic dancing class and are looking forward to crushing your workout. Unfortunately, the gym becomes an unanticipated battleground for ...
Read More
